000 03029cam a2200337 a 4500
003 EG-GiCUC
005 20250223031452.0
008 160407s2015 ua h f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.08.09.M.Sc.2015.No.S
100 0 _aNoha Fawzy Hassan
245 1 2 _aA Study on the possible therapeutic effects of whey protein products against hepatic fibrosis in experimental rats /
_cNoha Fawzy Hassan ; Supervised Ezz Eldin Said Eldenshary , Somia A. Nada
246 1 5 _aالدراسات العلاج{u٠٦أأ}ة المحتملة من منتجات مصل بروت{u٠٦أأ}ن اللبن على التل{u٠٦أأ}ف الكبدى فى الجرذان
260 _aCairo :
_bNoha Fawzy Hassan ,
_c2015
300 _a147 P. :
_bfacsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
520 _aInflammation and hepatic stellate cell (HSC) activation are the most crucial steps in the formation of hepatic fibrosis. Hepatocytes damaged by viral or bacterial infection, alcohol or toxic chemicals initiate an inflammatory response that activates collagen production by HSCs. Through this mechanism chronic administration of thioacetamide for 8 weeks at dose (100 mg/kg body weight) effectively induced liver injury and dysfunction and caused hepatic fibrosis. In this study, the effect of Betalactglobulin (Ý-LG), Lacprodan R alpha-10(LAC) and L-methionine were evaluated in TAA-induced hepatic fibrosis in rats. Method: Seventy two Sprague Dawley rats were divided into nine groups. Group 1 received saline only; all groups were injected with TAA two times / week, concurrently, Group3-4 received daily Ý-LG (100mg/kg and 200 mg/kg given orally), respectively.Group 5 received a combination of Ý-LG (50 mg/kg body weight) and l-methionine (40 mg/kg body weight).Groups 6,7 and 8were received the same as groups 3,4 and 5 except we use LAC instead of Ý-LG ,while group 9 was received L-methionine (40 mg/kg body weight) only. Results: TAA induced extensive liver damage that is evidenced by significant increase in serum levels of alanine amino transferase (ALT), Aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin(TB) .Moreover, TAA induced oxidative stress as indicated by significant increase in the hepatic lipid peroxidation (LPO)marker malondialdehyde (MDA) and nitric oxide content(NO) as well as significant decrease in antioxidant enzymes like hepatic reduced glutathione concentration (GSH) and superoxide dismutase (SOD) activities
530 _aIssued also as CD
653 4 _aHepatic fibrosis
653 4 _aLacprodan-alpha-10
653 4 _aThioacetamide
700 0 _aEzz Eldin Said Eldenshary ,
_eSupervisor
700 0 _aSomia Ahmed Nada ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAml
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c55908
_d55908